首页>The Journal of Infectious Diseases>Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment
Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment
作者单位：Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda[1]SEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako, Bamako, Mali[2]Division of Infectious Diseases, Northwestern University, Chicago, IL, United States[3]Center for Tuberculosis Research, Johns Hopkins University School of Medicine, 1550 Orleans St[4]
换一批
